Faulkingham Dell 4
4 · Akebia Therapeutics, Inc. · Filed Jun 3, 2019
Insider Transaction Report
Form 4
Transactions
- Award
Employee Stock Option (Right to buy)
2019-05-31+250,000→ 250,000 totalExercise: $4.45Exp: 2029-05-31→ Common Stock (250,000 underlying) - Award
Common Stock
2019-05-31+25,000→ 25,000 total
Footnotes (2)
- [F1]The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. 100% of the restricted stock units will vest on the first anniversary of the grant date.
- [F2]The options were granted by the Issuer as an inducement material to the reporting person's entering into employment with Akebia in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter.